Artificial Lung Market Developments Influencing Industry Expansion Through 2030

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Artificial Lung Market Compare Between 2026 And 2030?

The artificial lung market has experienced substantial expansion in recent years. Projections indicate its value will increase from $2.58 billion in 2025 to $2.88 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to its historical growth include the escalating occurrence of acute respiratory failure, the swift integration of heart-lung machines in cardiothoracic operations, an increase in organ transplant procedures, advancements in membrane artificial lung technology, and the expanding application of extracorporeal life support systems.

The artificial lung market size is expected to experience significant expansion in the coming years, with projections indicating it will reach $4.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.4%. This anticipated growth can be attributed to factors such as the increasing demand for critical care life-support devices, a growing emphasis on portable and compact artificial lung systems, rising investments in advanced oxygenation membrane materials, the expansion of their applications in emergency and trauma care, and the increasing adoption of minimally invasive extracorporeal support solutions. Key trends influencing this period include the escalating demand for artificial lung systems for severe respiratory failure and critical care management, the rising utilization of extracorporeal support devices in complex cardiac and lung transplant surgeries, a growing preference for minimally invasive and temporary lung support alternatives over transplantation, the increasing development of portable and transport-compatible artificial lung units for emergency settings, and the expanding use of membrane-based artificial lung technologies for efficient gas exchange and long-term support.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16591&type=smp

What Influential Factors Are Boosting The Artificial Lung Market Demand?

The rising occurrence of respiratory ailments is projected to advance the artificial lung market’s expansion. This increase in respiratory disease prevalence arises from several factors, including escalating air pollution, shifting climate patterns, and evolving lifestyle choices, which place a considerable burden on public health. Artificial lungs play a crucial role in managing respiratory conditions by delivering oxygen and extracting carbon dioxide from the bloodstream, thereby supporting or substituting compromised lung function. For example, in June 2024, the Australian Institute of Health and Welfare, an Australia-based health and welfare agency, reported that roughly 8.5 million people in Australia, representing 34% of the population, were estimated to be affected by chronic respiratory conditions. This figure encompasses an estimated 2.8 million people, or 11% of the population, suffering from asthma, and 638,000 people, or 2.5% of the population, living with chronic obstructive pulmonary disease (COPD). Consequently, the growing incidence of respiratory diseases is propelling the artificial lung market forward.

Which Segment Groups Define The Artificial Lung Market Landscape?

The artificial lung market covered in this report is segmented –

1) By Product Type: Single Roller Pump Heart Lung Machines, Double Roller Pump Heart Lungs Machines, Bubble Artificial Lung, Membrane Artificial Lung

2) By Application: Cardiac Surgery, Lung Transplant Operation, Acute Respiratory Failure Treatment, Other Applications

3) By End-Users: Hospital, Emergency Center, Other End-users

Subsegments:

1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines, Stationary Single Roller Pump Heart Lung Machines

2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines, Stationary Double Roller Pump Heart Lung Machines

3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung, Reusable Bubble Artificial Lung

4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung, Carbon Dioxide Removal Membrane Artificial Lung

What Trends Are Affecting The Growth Of The Artificial Lung Market?

Major companies operating in the artificial lung market are prioritizing the creation of innovative solutions, including truly portable pneumatic ECMO systems, to expand extracorporeal life support beyond the ICU and enable rapid transport and field deployment. A pneumatic portable ECMO system utilizes oxygen-supply-driven pneumatic pumps and integrated gas management to provide extracorporeal oxygenation and circulatory support without depending on external electric power or heavy motorized components. For instance, in May 2024, Hemovent GmbH, a Germany-based medical device company, announced that MOBYBOX, which is the world’s first integrated portable pneumatic ECMO system, completed its initial commercial applications in Europe. MOBYBOX weighs about 2.5 kg, is solely driven by the oxygen supply, allowing it to operate without a battery or motor, features Bionique Flow Technology for gentler blood handling and improved gas exchange, and has obtained Medical Device Regulation certification for initial markets.

Who Are The Firms Contributing To The Artificial Lung Market Ecosystem?

Major companies operating in the artificial lung market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co KGaA, ALung Technologies Inc, Xenios AG, Eurosets S.r.l, Nipro Corporation, Braile Biomédica, Hemovent GmbH, MC3 Cardiopulmonary Inc, Abbott Laboratories, Spectrum Medical Ltd, B Braun Melsungen AG, SB-Kawasumi Laboratories Inc, Senko Medical Instrument Mfg Co Ltd, CARMAT, Technowood International Pte Ltd, Elite Lifecare, Cytosorbents Corporation

Access The Complete Artificial Lung Market Report:

https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report

Which Region Accounts For The Highest Share Of The Artificial Lung Market?

North America was the largest region in the artificial lung market in 2025. The regions covered in the artificial lung market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Artificial Lung Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16591&type=smp

Browse Through More Reports Similar to the Global Artificial Lung Market 2026, By The Business Research Company

In Vitro Lung Model Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Artificial Intelligence Ai In Respiratory Diseases Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-respiratory-diseases-global-market-report

Respiratory Devices And Equipment Therapeutic Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795